Milind Foulger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Milind Foulger has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Arshia Ghodrati
Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA
1 shared publication - Christopher S. Gondi
University of Illinois Urbana-Champaign University of Illinois Urbana-Champaign University of Illinois Chicago University of Illinois Chicago University of Illinois Chicago University of Illinois Chicago University of Illinois at Urbana-Champaign University of Illinois Chicago University of Illinois Urbana-Champaign
1 shared publication - Lusine Demirkhanyan
Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA
1 shared publication - Zaphrirah S. Chin
Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL 61605, USA
1 shared publication
Latest Publications
- Open Access
- 12 June 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (6) , 349
Beyond Barriers: Achieving True Equity in Cancer Care
Healthcare disparities in cancer care remain pervasive, driven by intersecting socioeconomic, racial, and insurance-related inequities. These disparities manifest in various forms such as limited access to medical resources, underrepresentation in clinical trials, and worse cancer outcomes for marginalized groups, including low-income individuals, racial minorities, and those with inadequate insurance coverage, who face significant barriers in accessing comprehensive cancer care. This manuscript explores the multifaceted nature of these disparities, examining the roles of socioeconomic status, race, ethnicity, and insurance status in influencing cancer care access and outcomes. Historical and contemporary data highlight that minority racial status correlates with reduced clinical trial participation and increased cancer-related mortality. Barriers such as insurance coverage, health literacy, and language further hinder access to cancer treatments. Addressing these disparities requires a systemic approach that includes regulatory reforms, policy changes, educational initiatives, and innovative trial and treatment designs. This manuscript emphasizes the need for comprehensive interventions targeting biomedicine, socio-demographics, and social characteristics to mitigate these inequities. By understanding the underlying causes and implementing targeted strategies, we can work towards a more equitable healthcare system. This involves improving access to high-quality care, increasing participation in research, and addressing social determinants of health. This manuscript concludes with policy recommendations and future directions to achieve health equity in cancer care, ensuring optimal outcomes for all patients.
- 12 June 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (6) , 349
Open AccessBeyond Barriers: Achieving True Equity in Cancer Care
Healthcare disparities in cancer care remain pervasive, driven by intersecting socioeconomic, racial, and insurance-related inequities. These disparities manifest in various forms such as limited access to medical resources, underrepresentation in clinical trials, and worse cancer outcomes for marginalized groups, including low-income individuals, racial minorities, and those with inadequate insurance coverage, who face significant barriers in accessing comprehensive cancer care. This manuscript explores the multifaceted nature of these disparities, examining the roles of socioeconomic status, race, ethnicity, and insurance status in influencing cancer care access and outcomes. Historical and contemporary data highlight that minority racial status correlates with reduced clinical trial participation and increased cancer-related mortality. Barriers such as insurance coverage, health literacy, and language further hinder access to cancer treatments. Addressing these disparities requires a systemic approach that includes regulatory reforms, policy changes, educational initiatives, and innovative trial and treatment designs. This manuscript emphasizes the need for comprehensive interventions targeting biomedicine, socio-demographics, and social characteristics to mitigate these inequities. By understanding the underlying causes and implementing targeted strategies, we can work towards a more equitable healthcare system. This involves improving access to high-quality care, increasing participation in research, and addressing social determinants of health. This manuscript concludes with policy recommendations and future directions to achieve health equity in cancer care, ensuring optimal outcomes for all patients.